Arcus senilis is a term for the discoloration of the cornea, the transparent part of the eye that covers the pupil and iris. When the color change occurs, it presents as a white, bluish, or light gray ...

Arcus Biosciences presents a high-risk speculation with significant upcoming catalysts, despite recent stock declines and Gilead's exit from the ARC-10 trial. Gilead's continued investment and ...

If you want to know who really controls Arcus Biosciences, Inc. (NYSE:RCUS), then you'll have to look at the makeup of its share registry. With 51% stake, institutions possess the maximum shares ...

It can be hard to tell a scratched cornea (corneal abrasion) from pink eye (also known as conjunctivitis). They can have similar symptoms, including eye redness, tearing, and sensitivity to light.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Arcus Biosciences has a 12 month low of $6.50 and a 12 month high of $18.98. The stock’s 50 day moving average price is $10.13 and its 200 day moving average price is $13.80.

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...